Clinical Trials Browser

Leukemia, Large Granular Lymphocytic × ruxolitinib × 90 days × Clear all

NCT05592015 2026-02-10

Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Large Granular Lymphocytic